Biography and Research Information
OverviewAI-generated summary
Lindsey Barrett's research focuses on the study of viral infections and their impact on human health, with a particular emphasis on oncogenic viruses and their reactivation. Her work has investigated the role of SARS-CoV-2 proteins and anti-COVID-19 drugs in inducing the lytic reactivation of oncogenic viruses, as well as the association between Kaposi's sarcoma-associated herpesvirus and extracellular vesicles. Barrett has also explored potential therapeutic targets and natural compounds for diseases, including small-cell lung cancer and BCAT1. Her scholarship metrics include an h-index of 7, with a total of 9 publications and 136 citations. Barrett has established collaborations with several researchers at the University of Arkansas for Medical Sciences, including Lu Dai, Steven R. Post, Shengyu Mu, and Samantha Kendrick, with whom she shares multiple publications.
Metrics
- h-index: 7
- Publications: 9
- Citations: 141
Selected Publications
-
Identification of natural compounds tubercidin and lycorine HCl against small‐cell lung cancer and BCAT1 as a therapeutic target (2022)
-
Abstract LB072: SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus (2021)
-
SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus (2021)
-
Kaposi's sarcoma‐associated herpesvirus and extracellular vesicles (2021)
Collaboration Network
Top Collaborators
Lu Dai
Winthrop Rockefeller Foundation
4 shared publications
In database
- SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus
- Kaposi's sarcoma‐associated herpesvirus and extracellular vesicles
- Identification of natural compounds tubercidin and lycorine HCl against small‐cell lung cancer and BCAT1 as a therapeutic target
- Abstract LB072: SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus
Zhiqiang Qin
Winthrop Rockefeller Foundation (US)
4 shared publications
- SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus
- Kaposi's sarcoma‐associated herpesvirus and extracellular vesicles
- Identification of natural compounds tubercidin and lycorine HCl against small‐cell lung cancer and BCAT1 as a therapeutic target
- Abstract LB072: SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus
Jungang Chen
Winthrop Rockefeller Foundation (US)
3 shared publications
- SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus
- Identification of natural compounds tubercidin and lycorine HCl against small‐cell lung cancer and BCAT1 as a therapeutic target
- Abstract LB072: SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus
Steven R. Post
University of Arkansas for Medical Sciences
2 shared publications
In database
- SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus
- Abstract LB072: SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus
Shanzhi Wang
University of Arkansas at Little Rock (US)
1 shared publication
- Kaposi's sarcoma‐associated herpesvirus and extracellular vesicles
Jennifer James
Winthrop Rockefeller Foundation (US)
1 shared publication
- SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus
Karlie Plaisance‐Bonstaff
Louisiana State University Health Sciences Center New Orleans (US)
1 shared publication
- SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus
Zhen Lin
Tulane University (US)
1 shared publication
- Identification of natural compounds tubercidin and lycorine HCl against small‐cell lung cancer and BCAT1 as a therapeutic target
Samantha Kendrick
University of Arkansas for Medical Sciences
1 shared publication
In database
- Identification of natural compounds tubercidin and lycorine HCl against small‐cell lung cancer and BCAT1 as a therapeutic target
Shengyu Mu
University of Arkansas for Medical Sciences
1 shared publication
In database
- Identification of natural compounds tubercidin and lycorine HCl against small‐cell lung cancer and BCAT1 as a therapeutic target
Similar Researchers
Based on overlapping research topics
Steven R. Post
University of Arkansas for Medical Sciences
Viral Infections and Vectors
Cancer-related molecular mechanisms research
SARS-CoV-2 and COVID-19 Research
Jiao Song
University of Arkansas for Medical Sciences
Viral Infections and Vectors
Cancer-related molecular mechanisms research
SARS-CoV-2 and COVID-19 Research
Lu Dai
University of Arkansas for Medical Sciences
Viral Infections and Vectors
Cancer-related molecular mechanisms research
SARS-CoV-2 and COVID-19 Research
Timothy Ashby
University of Arkansas for Medical Sciences
Viral Infections and Vectors
SARS-CoV-2 and COVID-19 Research
Microbial infections and disease research
J. Craig Forrest
University of Arkansas for Medical Sciences
Viral Infections and Vectors
Cancer-related molecular mechanisms research
SARS-CoV-2 and COVID-19 Research
Lillie G. Wilson
University of Arkansas for Medical Sciences
Viral Infections and Vectors
Cancer-related molecular mechanisms research
Microbial infections and disease research